Hemophilia B Latest Advances
Find the Latest Research About Hemophilia B
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5549 publications
Corrigendum to 'Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial': [RPTH, 103360, January 2026, Volume 10, Issue 1].
Journal: Research and practice in thrombosis and haemostasis
Published: October 05, 2026
Cost-effectiveness of etranacogene dezaparvovec compared to eftrenonacog alfa for the treatment of adult patients with severe and moderately severe haemophilia B in Sweden.
Journal: Journal of medical economics
Published: October 04, 2026
Fidanacogene Elaparvovec Gene Therapy: Budesonide Treatment of a Late Decline in Factor IX Expression in a Patient with Hemophilia B.
Journal: International journal of molecular sciences
Published: September 14, 2026
Assessing the Carbon Footprint of Haemophilia B Gene Therapy: A Framework for Environmental Health Technology Assessment.
Journal: Journal of evaluation in clinical practice
Published: September 09, 2026
A Case Report on the Rare C.-35G>C F9 Variant and Genotype-Phenotype Analysis in Hemophilia B Leyden.
Journal: Seminars in thrombosis and hemostasis
Published: August 11, 2026
Multidisciplinary Management and Diagnostic Insights for Refractory Postoperative Hemorrhage in Mild Hemophilia B Caused by Hemizygous F9 c.881G>A (p.Arg294Gln) Variant
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 03, 2026
Clinical burden of haemophilia in Abu Dhabi, United Arab Emirates: real-world insights from the Malaffi platform.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: July 29, 2026
Correction to "Development of an Agent-Based Model to Investigate Durability of Factor IX Activity in Hemophilia B Patients Treated With Etranacogene Dezaparvovec".
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 28, 2026
Long-Term Durability and Safety Signals of Systemic AAV Gene Therapy for Haemophilia A and B: A Systematic Review.
Journal: European journal of haematology
Published: July 27, 2026
Occupational Therapy in Haemophilia Care: Perceived Role, Barriers and Expectations Among People With Haemophilia, Family Caregivers and Occupational Therapists.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 22, 2026
Retrospective evaluation of multidisciplinary perioperative hemostatic management in oral surgery for patients with hemophilia.
Journal: Journal of the Korean Association of Oral and Maxillofacial Surgeons
Published: July 20, 2026
Last Updated: 11/08/2026